Comparison - BCYC - NASDAQ

Weiss Ratings	BCYC - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Rating	E
Reward Index	Very Weak
Risk Index	Weak
Risk Grade	D
Reward Grade	E

Rating Factors	BCYC - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Dividend Index	--
Growth Index	Fair
Efficiency Index	Very Weak
Solvency Index	Excellent
Total Return Index	Very Weak
Volatility Index	Weak

Beta / Standard Deviation	BCYC - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Beta	0.96

Price History	BCYC - NASDAQ	Click to Compare	Click to Compare	Click to Compare
7-Day Total Return	-6.65%
30-Day Total Return	-24.12%
60-Day Total Return	-29.83%
90-Day Total Return	-58.67%
Year to Date Total Return	-32.52%
1-Year Total Return	-57.76%
2-Year Total Return	-55.26%
3-Year Total Return	-77.24%
5-Year Total Return	-27.79%
52-Week High % Change	-66.41%
52-Week Low % Change	0.52%

Price	BCYC - NASDAQ	Click to Compare	Click to Compare	Click to Compare
52-Week High Price	$28.67
52-Week Low Price	$9.58
52-Week Low Price (Date)	Mar 10, 2025
52-Week High Price (Date)	Oct 16, 2024

Valuation	BCYC - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Market Cap	666.42M
Enterprise Value	-203.61M
Price/Earnings (TTM)	--
Earnings Per Share (TTM)	-2.88
Earnings Per Share Growth	-43.93%
Price/Earnings To Growth	--
Price/Sales (TTM)	18.85
Price/Book (Q)	0.84
Enterprise Value/Revenue (TTM)	-5.77
Price	$9.69
Enterprise Value/EBITDA (TTM)	1.00
Enterprise Value/EBIT	0.97
Market Cap Category	Small Cap

Dividends and Shares	BCYC - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Shares Outstanding	69.05M
Dividend Yield	--
Div. Per Share (Most Recent)	--
Dividend Per Share (TTM)	--
Payout Ratio (TTM)	--
Dividend Per Share (Most Recent)	--

Company Info	BCYC - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Phone Number	44 1223 261 503
Address	--
Website	www.bicycletherapeutics.com
Country	United Kingdom
Year Founded	2009

Profitability	BCYC - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Operating Margin (TTM)	-594.95%
Profit Margin	-479.18%

Management Effectiveness	BCYC - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Return on Assets	-16.90%
Return on Equity	--

Income Statement	BCYC - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Revenue (TTM)	35.28M
Total Revenue (TTM)	35.28M
Revenue Per Share	$0.51
Gross Profit (TTM)	-17.09M
EBITDA (TTM)	-202.70M
EBIT (TTM)	-209.87M
Net Income (TTM)	-169.03M
Net Income Avl. to Common (TTM)	-169.03M
Total Revenue Growth (Q YOY)	-30.44%
Earnings Growth (Q YOY)	-5.61%
EPS Diluted (TTM)	-2.88
EPS Diluted Growth (Q YOY)	35.13%

Balance Sheet	BCYC - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Cash and Short-Term Inv. (Q)	879.52M
Cash Per Share (Q)	$12.74
Total Current Assets (Q)	928.61M
Total Preferred Equity (Q)	--
Total Equity (Q)	793.06M
Current Ratio (Q)	13.812
Book Value Per Share (Q)	$11.48
Total Assets (Q)	956.87M
Total Current Liabilities (Q)	67.23M
Total Debt (Q)	13.48M
Total Liabilities (Q)	163.81M
Total Common Equity (Q)	793.06M

Cash Flow	BCYC - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Cash from Investing (TTM)	-1.24M
Cash from Financing (TTM)	519.75M
Net Change in Cash (TTM)	353.10M
Levered Free Cash Flow (TTM)	-130.91M
Cash from Operations (TTM)	-164.72M